Aspire BioPharma, Inc. (ASBP) — Capital Reinvestment Ratio

Latest as of December 2024: 0.00x

Aspire BioPharma, Inc. (ASBP) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow ($479.57K) in capital expenditures ($4.00). See cash generation quality of Aspire BioPharma, Inc. to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$479.57K
USD

Capital Expenditures

$4.00
USD

Data as of

Dec 2024
Most recent filing

Annual Capital Reinvestment Ratio for Aspire BioPharma, Inc. (None–None)

Year-by-year Capital Reinvestment Ratio for Aspire BioPharma, Inc. from None to None. For live market cap and broader valuation context, see Aspire BioPharma, Inc. stock valuation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow